NCT01846468 An Ascending Dose Study to Assess Safety, Tolerability, PK/PD of LHW090 in Healthy Volunteers and in Subjects With Renal Dysfunction Status COMPLETED Phase PHASE1
NCT01846299 To Assess the Efficacy and Safety of Intravitreal Ranibizumab in People With Vision Loss Due to Macular Edema Status COMPLETED Phase PHASE3
NCT01846273 Visual Outcome in Patients With Symptomatic Macular Polypoidal Choroidal Vasculopathy (PCV) Treated With Either Ranibizumab as Monotherapy or Combined With Verteporfin Photodynamic Therapy (vPDT) Status COMPLETED Phase PHASE4
NCT01845623 A Study to Evaluate the Effects of Indacaterol Maleate (QAB149) as a New Formulation in the EPIC Test Fixture Status WITHDRAWN Phase PHASE2
NCT01845025 Study of Safety of Foradil in Patients With Persistent Asthma Status TERMINATED Phase PHASE4
NCT01844778 Ease of Use and Microbial Contamination of Tobramycin Inhalation Powder (TIP) Versus Nebulised Tobramycin Inhalation Solution (TIS) and Nebulised Colistimethate (COLI) Status COMPLETED Phase PHASE4
NCT01844765 Open Label, Phase II Study to Evaluate Efficacy and Safety of Oral Nilotinib in Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia (CML) Pediatric Patients. Status COMPLETED Phase PHASE2
NCT01843348 12 Month Athena Study: Everolimus vs. Standard Regimen in de Novo Kidney Transplant Patients Status COMPLETED Phase PHASE3
NCT01840410 Assess the Efficacy/Safety of Intravitreal Ranibizumab in Patients With Vision Loss Due to Choroidal Neovascularization. Status COMPLETED Phase PHASE3
NCT01837927 Efficacy of NVA237 (50 μg o.d) Using Tiotropium (5μg μg o.d) as Active Control in COPD Patients. Status WITHDRAWN Phase PHASE3
NCT01836471 A Study to Assess the Effect of QAW039 in Non-atopic Asthmatic Patients Status COMPLETED Phase PHASE2
NCT01836458 A Study to Find the Minimum Inhibitory Concentration of KAE609 in Adult Male Patients With P. Falciparum Monoinfection Status COMPLETED Phase PHASE2
NCT01834885 A 12 Week Study of QVA149 Compared to Fluticasone/Salmeterol (Advair) for Treatment of COPD Status WITHDRAWN Phase PHASE3
NCT01831947 Efficacy Study of Ranibizumab on Patients With Age-related Macular Degeneration. Status COMPLETED Phase PHASE4
NCT01831726 Dovitinib for Patients With Tumor Pathway Activations Inhibited by Dovitinib Status COMPLETED Phase PHASE2
NCT01830361 Trial to Assess the Efficacy of Midostaurin (PKC412) in Patients With c-KIT or FLT3-ITD Mutated t(8;21) AML Status COMPLETED Phase PHASE2
NCT01830010 A Two-part Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of KRP203 in Patients Undergoing Stem Cell Transplant for Hematological Malignancies Status COMPLETED Phase PHASE1
NCT01828112 LDK378 Versus Chemotherapy in ALK Rearranged (ALK Positive) Patients Previously Treated With Chemotherapy (Platinum Doublet) and Crizotinib Status COMPLETED Phase PHASE3
NCT01828099 LDK378 Versus Chemotherapy in Previously Untreated Patients With ALK Rearranged Non-small Cell Lung Cancer Status COMPLETED Phase PHASE3